Neural-tube defects and antiretroviral treatment regimens in Botswana

…, G Mayondi, A Isaacson, S Davey… - … England Journal of …, 2019 - Mass Medical Soc
Background A preliminary safety signal for neural-tube defects was previously reported in
association with dolutegravir exposure from the time of conception, which has affected choices …

Disparities in SARS-CoV-2 testing in Massachusetts during the COVID-19 pandemic

…, GE Velásquez, TJ Stopka, S Davey… - JAMA network …, 2021 - jamanetwork.com
Early deficiencies in testing capacity have contributed to poor control of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), 1 particularly among minority (ie, Black and …

IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts

…, FK Noubissi, PS Katti, CM Hahn, SR Davey… - …, 2013 - academic.oup.com
Igf2 mRNA binding protein 1 (IMP1, CRD-BP, ZBP-1) is a messenger RNA binding protein
that we have shown previously to regulate colorectal cancer (CRC) cell growth in vitro . …

[HTML][HTML] The economic burden of non-fatal musculoskeletal injuries in Northeastern Tanzania

S Davey, E Bulat, H Massawe, A Pallangyo… - Annals of global …, 2019 - ncbi.nlm.nih.gov
Background: Although musculoskeletal injuries have increased in sub-Saharan Africa, data
on the economic burden of non-fatal musculoskeletal injuries in this region are scarce. …

Weight gain during pregnancy among women initiating dolutegravir in Botswana

…, R Shapiro, M Diseko, BJ Wylie, C Zera, S Davey… - …, 2020 - thelancet.com
Background Recent data suggests clinically significant weight gain among non-pregnant
HIV-positive adults after starting dolutegravir-based ART (DTG). Excess or insufficient weight …

Mother-to-child HIV transmission with in utero dolutegravir vs. efavirenz in Botswana

S Davey, G Ajibola, K Maswabi, M Sakoi… - JAIDS Journal of …, 2020 - journals.lww.com
Background: A large-scale evaluation of mother-to-child transmission (MTCT) with dolutegravir
(DTG)-based antiretroviral treatment (ART) has not been conducted previously. Setting: …

Severe acute respiratory syndrome coronavirus 2 vaccine immunogenicity among chimeric antigen receptor T cell therapy recipients

MM Aleissa, JS Little, S Davey, A Saucier… - … and cellular therapy, 2023 - Elsevier
Patients receiving chimeric antigen receptor T cell (CAR-T) therapy may have impaired
humoral responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV

…, R Bhatia, M Bvochora-Nsingo, S Davey… - JAIDS Journal of …, 2020 - journals.lww.com
Background: In Botswana, nearly two-thirds of cervical cancer patients are HIV-positive. This
study examined the relationship between CD4 count and chemoradiation therapy outcomes …

SARS-CoV-2 vaccine-induced immune responses among hematopoietic stem cell transplant recipients

…, M Aleissa, AM Lupan, S Davey… - Open Forum …, 2023 - academic.oup.com
Background Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination reduces the risk and severity of coronavirus disease 2019 (COVID-19), several …

Deletion of Ubiquitin Fold Modifier Protein Ufm1 Processing Peptidase Ufsp in L. donovani Abolishes Ufm1 Processing and Alters Pathogenesis

S Gannavaram, S Davey, I Lakhal-Naouar… - PLoS neglected …, 2014 - journals.plos.org
Previously, we showed Leishmania donovani Ufm1 has a Gly residue conserved at the C-terminal
region with a unique 17 amino acid residue extension that must be processed prior to …